Annolyse
BriefingsCompaniesInsightsPrinciplesCompareWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • Developers

© 2026 Annolyse. Analytical briefings for NZX company announcements.

Table of contents

  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material
←Back to briefings
Iperion (IPR) / FY21

Interest income halved to NZ$25.3m as the NZ$2.1b cash shell waited on M&A

FY21 loss narrowed 26.4% to NZ$117.6m but revenue collapsed 50.9% with no acquisition yet deployed from the NZ$2.1b cash pile.

Release date
31 May 2021
Published
22 April 2026
Table of Contents⌄
  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material

What changed

Revenue, which is disclosed as interest income, fell 50.9% to NZ$25.3m from NZ$51.5m in FY20 — consistent with a lower-rate environment on a large cash balance rather than any operating activity. The headline loss narrowed 26.4% to NZ$117.6m (PBT and NPAT identical; no tax in either year). Operating cash outflow improved to NZ$123.6m from NZ$159.9m, and the cash balance fell NZ$123.6m to NZ$2.1b. Total assets declined 5.5% to NZ$2.2b and equity 5.4% to NZ$2.1b, essentially tracking the full-year loss. No dividend was declared.

What matters

  • The business is, for now, a cash-holding vehicle. Revenue is interest income and the 50.9% revenue fall reflects the yield on NZ$2.1b of cash, not operational performance. The loss of NZ$117.6m against NZ$25.3m of interest income implies roughly NZ$143m of costs/outflows being absorbed by the cash base each year.
  • Cash is being consumed at a material absolute rate. Operating cash outflow of NZ$123.6m is ~5.8% of opening cash. The improvement from FY20 (-NZ$159.9m) is real but the trajectory still depletes optionality if no acquisition closes.
  • Stated strategy remains "seeking acquisition targets." No target company, deal size, return hurdle or timeline has been disclosed, so the read on strategy progress is unchanged year on year.

Expectations

No formal financial targets, forward-work book, or quantitative guidance were provided. Seasonality is not particularly meaningful for an interest-bearing cash vehicle, but the HY21/FY21 split is informative: HY21 carried 72.1% of FY21 revenue and only 50.3% of the full-year loss, implying H2 revenue of just NZ$7.0m and H2 loss of NZ$58.5m. The H2 revenue step-down points to a further yield compression through the year; the loss run-rate was broadly stable half-on-half. Absent disclosed targets, the release supports neither a re-rating case nor a deterioration case — it supports only the status quo of a cash pile slowly shrinking while management searches for deployment.

Quality of result

The narrower loss is mechanically driven by the smaller gap between interest income and fixed operating costs of the vehicle; it is not evidence of operating improvement. With no EBITDA, capex, working-capital, or borrowings disclosure in the extraction, conventional quality tests cannot be applied. What can be said: NPAT (-NZ$117.6m) and operating cash outflow (-NZ$123.6m) are closely aligned, so there is no obvious accrual/cash divergence masking the result. The balance-sheet move (equity down NZ$117.6m, cash down NZ$123.6m, assets down NZ$125.3m) is internally consistent with the reported loss. The result is therefore durable in the sense that it is not timing-assisted — but it is also structurally dependent on prevailing interest rates on the cash balance.

Unresolved

  • What is the composition of the NZ$143m-ish annual cost line that turns NZ$25.3m of interest income into a NZ$117.6m loss? The release excerpts do not break this out.
  • What is the status, size, and timing of the acquisition targets referenced? No pipeline, mandate, or hurdle rate has been quantified.
  • What yield is currently being earned on the NZ$2.1b cash balance, and how sensitive is revenue to further rate moves?
  • Is any portion of the cash restricted, committed, or earmarked, and on what terms is it held?
  • Are there any contingent liabilities or off-balance-sheet obligations behind the NZ$83.4m of total liabilities?

This briefing cannot assess the economic substance of the vehicle, the identity or viability of acquisition targets, or whether the cash balance is fully available for redeployment, because those details are not in the supplied extraction.

Key metrics

← Swipe to view more
Key metrics table for Iperion FY21
Metric FY21 FY20 Change
Revenue $25.3m $51.5m -50.9% ↓
Net profit after tax −$117.6m −$159.9m +26.4% ↑
Net cash inflow from operating activities −$123.6m −$159.9m +22.7% ↑
Profit before tax −$117.6m −$159.9m +26.4% ↑
Total assets $2.2b $2.3b -5.5% ↓

Analytical metrics

← Swipe to view more
Analytical metrics table for Iperion FY21
Metric FY21 FY20 Context
ROE (annualised) -5.7% -7.3% Strengthening
HY21 share of FY21 revenue 72.1% — Other half was 27.9%
HY21 share of FY21 NPAT 50.3% — Other half was 49.7%
Profit from continuing operations −$117.6m −$159.9m +$42.3m

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Source-backed analysis from the filing set attached to this briefing.

Metric context

Trajectory before this result

A compact view of the company's recent revenue and margin path, derived from the same metrics history that powers the company page.

IPR revenue trajectory

Revenue context before the current result.

← Swipe to view more
IPR revenue trajectory preview table
PeriodIPR
FY24$0m
HY24$20.8m
FY23$26.1m
HY23$10.3m
FY22$11.3m
HY22$4m

IPR EBITDA margin

Earnings margin across covered periods.

← Swipe to view more
IPR EBITDA margin preview table
PeriodIPR
FY24n/a
HY24n/a
FY23-1.1%
HY23-1.3%
FY22n/a
HY22n/a

Appendix

Reference material

Company materials considered in this briefing.

Current period

SNC Preliminary Full Year Result 2021

FY21 / financial report↗

Prior comparable period

SNC FY20 Annual Report

FY20 / financial report↗

SNC FY20 Results Announcement

FY20 / results announcement↗

SNC FY20 Results Announcement

FY20 / results release↗

Interim context

SNC 1H21 Interim Report

HY21 / financial report↗

SNC 1H21 NZX Results Template

HY21 / results announcement↗

Related insight

See how earnings quality compares across covered companies

→

Email updates

Want briefings like this for the next reporting season?

Get the next Annolyse briefing by email when it is published.

IPR revenue trajectory

Revenue context before the current result.

IPR EBITDA margin

Earnings margin across covered periods.